TCL Archive In Brief: FDA Approves Two Alpha Interferons; Canellos to Give Schwartz Lecture At Scripps Meeting June 13, 1986
TCL Archive Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study January 28, 2011
TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
